The circ‐0102231/miR‐635/NOVA2 regulatory axis reveals a functional role for circRNAs in NSCLC progression through modulation of the PI3K/AKT pathway, offering a new therapeutic angle. Here, PIK3CD is linked to non-small cell lung carcinoma.